# OnCo record luminary-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/luminary-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "luminary-therapeutics" ;
  schema:name "Luminary Therapeutics"@en ;
  schema:alternateName "Luminary Therapeutics, Inc."@en ;
  schema:description "Luminary Therapeutics is a Minneapolis company making CAR-T cells, immune cells engineered to find cancer, that use the natural BAFF ligand to hit three receptors on B cells at once. Its first product, LMY-920, is in early trials in lymphoma, myeloma and leukaemia."@en ;
  schema:url <https://onco.cc/companies/luminary-therapeutics/>, <https://www.luminarytx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.luminarytx.com/>, <https://www.luminarytx.com/pipeline/>, <https://reporter.nih.gov/project-details/11421504> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/gamma-delta-t-cell-therapy/>, <https://onco.cc/technologies/allogeneic-cell-therapy/> ;
  onco:drugs <https://onco.cc/drugs/lmy-920/> .